Physician profile
Michael W Marcus
NPI 1669571253
$4,070.81
in general payments reported to CMS, 2019-2025
17 companies · $21.18 in 2025
The $21.18 reported for 2025 was less than what a typical Child & Adolescent Psychiatry provider received nationally (typical 2025 total: $132).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,259 · 2020: $433 · 2021: $322 · 2022: $889 · 2023: $84.47 · 2024: $62.25 · 2025: $21.18.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $167.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $1,145.49 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $916.70 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $454.82 | 2019-2023 | Rexulti |
| Allergan, INC. | $240.55 | 2019-2020 | |
| Abbvie INC. | $219.23 | 2021-2024 | |
| Janssen Pharmaceuticals, INC | $202.50 | 2019-2020 | |
| Shire North American Group INC | $151.33 | 2019 | |
| Lundbeck LLC | $124.79 | 2019-2022 | |
| Neurocrine Biosciences, INC. | $115.96 | 2019-2024 | Ingrezza |
| Ironshore Pharmaceuticals INC. | $104.35 | 2019-2021 | |
| Avanir Pharmaceuticals, INC. | $97.83 | 2019-2020 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $96.00 | 2021-2022 | |
| Indivior INC. | $62.30 | 2019 | |
| Neos Therapeutics, LP | $54.84 | 2019 | |
| Corium, LLC | $44.95 | 2022-2023 | Azstarys |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vanda Pharmaceuticals INC. | $21.18 | 2025 | Fanapt |
| Supernus Pharmaceuticals, INC. | $17.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Marcus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.